Incannex Healthcare Statistics
Total Valuation
IXHL has a market cap or net worth of $16.00 million. The enterprise value is $18.00 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IXHL has 27.55 million shares outstanding. The number of shares has increased by 7.18% in one year.
| Current Share Class | 27.55M |
| Shares Outstanding | 27.55M |
| Shares Change (YoY) | +7.18% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 11.60% |
| Owned by Institutions (%) | 15.26% |
| Float | 21.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 100.85 |
| Forward PS | 25.54 |
| PB Ratio | 10.71 |
| P/TBV Ratio | 16.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 183.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 4.25.
| Current Ratio | 1.80 |
| Quick Ratio | 1.53 |
| Debt / Equity | 4.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -128.92 |
Financial Efficiency
Return on equity (ROE) is -240.00% and return on invested capital (ROIC) is -112.92%.
| Return on Equity (ROE) | -240.00% |
| Return on Assets (ROA) | -82.35% |
| Return on Invested Capital (ROIC) | -112.92% |
| Return on Capital Employed (ROCE) | -418.65% |
| Revenue Per Employee | $10,889 |
| Profits Per Employee | -$2.64M |
| Employee Count | 9 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IXHL has paid $30,000 in taxes.
| Income Tax | 30,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.23% in the last 52 weeks. The beta is 2.13, so IXHL's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | -73.23% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 40.36 |
| Average Volume (20 Days) | 318,087 |
Short Selling Information
The latest short interest is 195,642, so 0.71% of the outstanding shares have been sold short.
| Short Interest | 195,642 |
| Short Previous Month | 71,825 |
| Short % of Shares Out | 0.71% |
| Short % of Float | 0.90% |
| Short Ratio (days to cover) | 0.63 |
Income Statement
In the last 12 months, IXHL had revenue of $98,000 and -$23.80 million in losses. Loss per share was -$1.40.
| Revenue | 98,000 |
| Gross Profit | 98,000 |
| Operating Income | -22.05M |
| Pretax Income | n/a |
| Net Income | -23.80M |
| EBITDA | -21.78M |
| EBIT | -22.05M |
| Loss Per Share | -$1.40 |
Full Income StatementBalance Sheet
The company has $2.10 million in cash and $4.10 million in debt, giving a net cash position of -$2.00 million or -$0.07 per share.
| Cash & Cash Equivalents | 2.10M |
| Total Debt | 4.10M |
| Net Cash | -2.00M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 965,000 |
| Book Value Per Share | 0.05 |
| Working Capital | 4.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.87 million and capital expenditures -$5,000, giving a free cash flow of -$15.87 million.
| Operating Cash Flow | -15.87M |
| Capital Expenditures | -5,000 |
| Free Cash Flow | -15.87M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -22,495.92% |
| Pretax Margin | -24,259.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |